India-US healthcare collaboration in spotlight

India-US collaboration in the health sector is in the spotlight as the Central Drug Authority this week approved two more Covid vaccines - Corbevax and Covovax - and antiviral drug Molnupiravir for use in India. Taranjit Singh Sandhu, India's Ambassador to the US, in a tweet described it as a model of India-US healthcare collaboration. "Models of what India-United States healthcare collaboration can achieve for global good!" Sandhu said.
Indian companies working with Texas Children's, Baylor College of Medicine's National School of Tropical Medicine; Dr. Peter Hotez, Prof and Dean of the National School of Tropical Medicine at Baylor and Co-Director of the Texas Children's Hospital Center for Vaccine Development; NovaVax; Merck and Ridgeback Bio, tweeted the Indian diplomat.